Joint Corp director receives 5,714 share grant

Karrmann Sandra R reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Karrmann Sandra R reported acquisition or exercise transactions in this Form 4 filing.

JOINT Corp director Sandra R. Karrmann received a grant of 5,714 shares of restricted common stock, with no cash paid per share. These restricted shares vest in full on the earlier of May 20, 2027 or the next annual meeting of stockholders. Following this award, she directly holds 10,563 common shares.

Insider Trade Summary

Grant/Award: 5,714 shares

Grant/Award 1 txn

Insider Karrmann Sandra R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,714	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,563 shares (Direct)

Footnotes (1)

F1. All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027 and (ii) the date of the next annual meeting of the stockholders of The Joint Corp.

Key Figures

Restricted shares granted: 5,714 shares Grant price per share: $0.00 per share Shares held after grant: 10,563 shares +1 more

4 metrics

Restricted shares granted 5,714 shares Grant of restricted common stock to director on May 20, 2026

Grant price per share $0.00 per share Recorded transaction price for the restricted stock award

Shares held after grant 10,563 shares Director’s direct common stock holdings following the award

Vesting date May 20, 2027 Latest date when restricted shares vest, earlier if next annual meeting occurs first

Key Terms

restricted shares, vesting, annual meeting of the stockholders

3 terms

restricted shares financial

"All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027..."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vesting financial

"All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of the stockholders financial

"...or (ii) the date of the next annual meeting of the stockholders of The Joint Corp."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did JOINT Corp (JYNT) report for Sandra R. Karrmann?

JOINT Corp reported that director Sandra R. Karrmann received a grant of 5,714 shares of restricted common stock. The award was recorded at a price of $0.00 per share as part of her equity compensation.

How many JOINT Corp (JYNT) shares does Sandra R. Karrmann hold after this Form 4?

After the restricted stock grant, Sandra R. Karrmann directly holds 10,563 shares of JOINT Corp common stock. This total reflects her position immediately following the award reported in the Form 4 filing.

When do Sandra R. Karrmann’s JOINT Corp (JYNT) restricted shares vest?

The 5,714 restricted shares vest in full on the earlier of May 20, 2027, or the date of JOINT Corp’s next annual meeting of stockholders. Vesting means the shares become fully owned without restrictions.

Was Sandra R. Karrmann’s JOINT Corp (JYNT) grant a market purchase or compensation award?

The transaction was coded as a grant or award acquisition, not a market purchase. The shares were issued at $0.00 per share, indicating compensation rather than an open-market buy order.

Are the newly granted JOINT Corp (JYNT) shares for Sandra R. Karrmann restricted?

Yes, all 5,714 shares granted to Sandra R. Karrmann are restricted shares. They are subject to vesting conditions and will vest in full on the earlier of May 20, 2027, or the next annual stockholder meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/22/2026 - 04:16 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Karrmann Sandra R

(Last)

(First)

(Middle)

16767 NORTH PERIMETER DRIVE

SUITE 110

(Street)

SCOTTSDALE

ARIZONA

85260

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOINT Corp [ JYNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/20/2026		A		5,714⁽¹⁾	A	$0	10,563	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027 and (ii) the date of the next annual meeting of the stockholders of The Joint Corp.

Remarks:

Exhibit List 24 - Limited Power of Attorney

	/s/ Andra Terrell, as attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR